Top Markets
#1 Black Phoenix Black Phoenix +367.29%
#2 Islamic Coin Islamic Coin +158.24%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +55.02%
#5 Akedo Akedo +53.30%
#6 Acurast Acurast +37.40%
#7 BasedHype BasedHype +30.34%
#8 Cryptopia Cryptopia +22.42%
#9 Avantis Avantis +21.94%
#10 Playnance Playnance +19.70%
Coin of the day
Black Phoenix Black Phoenix
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Kedudukan dalam Saham #41091
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Harga Saham
$0.0202
Disegerakkan terakhir: 2024-11-19
Modal Pasaran
$44.67K
Perubahan (1 hari)
-0.49%
Perubahan (1 tahun)
0.00%
Negara
IL
Perdagangan Notable Labs, Ltd. (NTBL)

Kategori

Healthcare
Nisbah P/B bagi Notable Labs, Ltd. (NTBL)
Nisbah P/B pada August 2026 TTM: 0.04
Menurut laporan kewangan dan harga saham terkini Notable Labs, Ltd., nisbah P/B semasa (TTM) ialah 0.04. Pada akhir 2022, nisbah P/B syarikat ialah -0.25.
Sejarah nisbah P/B untuk Notable Labs, Ltd. dari 2015 hingga 2026
Nisbah P/B pada akhir setiap tahun
Tahun Nisbah P/B Ubah
2026 (TTM) 0.04 -86.41%
2023 0.27 -208.34%
2022 -0.25 -99.73%
2021 -93.37 -186.36%
2020 108.12 83.51%
2019 58.92 179.46%
2018 21.08 -82.69%
2017 121.80 21.83%
2016 99.97 -6.40%
2015 106.81 0.00%
Nisbah P/B untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/B Perbezaan Nisbah P/B Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 16,960.76%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 17,197.82%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 9,801.91%
BE